Zimmer Biomet Holdings Inc (ZBH) Files 10-K for the Fiscal Year Ended on December 31, 2018

Zimmer Biomet Holdings Inc (NYSE:ZBH) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Zimmer Biomet Holdings Inc is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, Persona, Zimmer, and Polaris. Zimmer Biomet Holdings Inc has a market cap of $25.36 billion; its shares were traded at around $124.33 with and P/S ratio of 3.22. The dividend yield of Zimmer Biomet Holdings Inc stocks is 0.77%. Zimmer Biomet Holdings Inc had annual average EBITDA growth of 0.30% over the past ten years.

For the last quarter Zimmer Biomet Holdings Inc reported a revenue of $2.1 billion, compared with the revenue of $2.1 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $7.9 billion, an increase of 1.4% from last year. For the last five years Zimmer Biomet Holdings Inc had an average revenue growth rate of 13.7% a year.

The reported loss per diluted share was $1.86 for the year, compared with the earnings per share of $1.51 in the previous year. The Zimmer Biomet Holdings Inc had a decent operating margin of 14.46%, compared with the operating margin of 17.22% a year before. The 10-year historical median operating margin of Zimmer Biomet Holdings Inc is 24.89%. The profitability rank of the company is 7 (out of 10).

At the end of the fiscal year, Zimmer Biomet Holdings Inc has the cash and cash equivalents of $542.8 million, compared with $524.4 million in the previous year. The long term debt was $8.4 billion, compared with $8.9 billion in the previous year. The interest coverage to the debt is 3.9. Zimmer Biomet Holdings Inc has a financial strength rank of 5 (out of 10).

At the current stock price of $124.33, Zimmer Biomet Holdings Inc is traded at close to its historical median P/S valuation band of $117.45. The P/S ratio of the stock is 3.22, while the historical median P/S ratio is 3.03. The stock gained 5.06% during the past 12 months.

CEO Recent Trades:

President and CEO Bryan C Hanson bought 2,100 shares of ZBH stock on 02/07/2019 at the average price of $119.02. The price of the stock has increased by 4.46% since.

Directors and Officers Recent Trades:

Director Arthur J Higgins bought 500 shares of ZBH stock on 02/15/2019 at the average price of $123.28. The price of the stock has increased by 0.85% since.Director Michael J. Farrell bought 2,000 shares of ZBH stock on 02/13/2019 at the average price of $123.62. The price of the stock has increased by 0.57% since.Director Larry C Glasscock bought 2,000 shares of ZBH stock on 02/08/2019 at the average price of $120.09. The price of the stock has increased by 3.53% since.Director Michael W Michelson bought 2,085 shares of ZBH stock on 02/08/2019 at the average price of $119.69. The price of the stock has increased by 3.88% since.Director Maria Teresa Hilado bought 1,650 shares of ZBH stock on 02/07/2019 at the average price of $118.18. The price of the stock has increased by 5.2% since.

For the complete 20-year historical financial data of ZBH, click here.